参考文献/References:
[1] Bao W,Rong Y,Rong S,et al.Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis[J].BMC Med,2012,10:119.DOI:10.1186/1741-7015-10-119.
[2] Pechlaner R,Weiss G,Bansal S,et al.Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus[J].Diabetes Metab Res Rev,2016,32(2):187-192.DOI:10.1002/dmrr.2711.
[3] Batchuluun B,Matsumata T,Batchuluun B,et al.Serum ferritin level is higher in poorly controlled patients with type 2 diabetes and people without diabetes, aged over 55 years[J].Diabet Med,2014,31(4):419-424.DOI:10.1111/dme.12343.
[4] Lee HJ,Choi JS,Lee HJ,et al.Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction[J].J Nutr Biochem,2015,26(12):1414-1423.DOI:10.1016/j.jnutbio.2015.07.008.
[5] Cooksey RC,Jones D,Gabrielsen S,et al.Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese(ob/ob lep-/-)mouse[J].Am J Physiol Endocrinol Metab,2010,298(6):E1236-E1243.DOI:10.1152/ajpendo.00022.2010.
[6] Mehdad A,Campos NA,Arruda SF,et al.Iron deprivation may enhance insulin receptor and Glut4 transcription in skeletal muscle of adult rats[J].J Nutr Health Aging,2015,19(8):846-854.DOI:10.1007/s12603-015-0541-9.
[7] Andrews Guzmán M,Arredondo Olguín M.Association between ferritin, high sensitivity C-reactive protein(hsCRP)and relative abundance of Hepcidin mRNA with the risk of type 2 diabetes in obese subjects[J].Nutr Hosp,2014,30(3):577-584.DOI:10.3305/nh.2014.30.3.7647.
[8] Gabrielsen JS,Gao Y,Simcox JA,et al. Adipocyte iron regulates adiponectin and insulin sensitivity[J].J Clin Invest,2012,122(10):3529-3540.DOI:10.1172/JCI44421.
[9] Kim CW,Chang Y,Sung E,et al.Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men[J].Metabolism,2012,61(8):1182-1188.DOI:10.1016/j.metabol.2012.01.007.
[10] Kowdley KV,Belt P,Wilson LA,et al.Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J].Hepatology,2012,55(1):77-85.DOI:10.1002/hep.24706.
[11] Nelson JE,Wilson L,Brunt EM,et al.Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease[J].Hepatology,2011,53(2):448-457.DOI:10.1002/hep.24038.
[12] Maliken BD,Nelson JE,Klintworth HM,et al.Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease[J].Hepatology,2013,57(5):1806-1813.DOI:10.1002/hep.26238.
[13] 武玉平, 叶琪, 郑全森, 等. 游离脂肪酸和铁诱导非酒精性脂肪肝病的协同作用机制研究[J]. 中华预防医学杂志, 2014,48(10):904-908.DOI:10.3760/cma.j.issm.0253-9624.2014.10.012.
[14] Graham RM,Chua AC,Carter KW,et al. Hepatic iron loading in mice increases cholesterol biosynthesis[J].Hepatology,2010,52(2):462-471.DOI:10.1002/hep.23712.
[15] Ruddell RG,Hoang-Le D,Barwood JM,et al.Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells[J].Hepatology,2009,49(3):887-900.DOI:10.1002/hep.22716.
[16] Otogawa K,Kinoshita K,Fujii H,et al. Erythrophagocytosis by liver macrophages(Kupffer cells)promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis[J].Am J Pathol,2007,170(3):967-980.DOI:10.2353/ajpath.2007.060441.
[17] Valenti L,Varenna M,Fracanzani AL,et al.Association between iron overload and osteoporosis in patients with hereditary hemochromatosis[J].Osteoporos Int,2009,20(4):549-555.DOI:10.1007/s00198-008-0701-4.
[18] Kim BJ,Ahn SH,Bae SJ,et al.Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study[J].J Bone Miner Res,2012,27(11):2279-2290.DOI:10.1002/jbmr.1692.
[19] Kim BJ,Lee SH,Koh JM,et al.The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age(KNHANES 2008-2010)[J].Osteoporos Int,2013,24(10):2627-2637.DOI:10.1007/s00198-013-2363-0.
[20] 王兵, 赵环, 姜习凤, 等. 绝经后女性股骨头铁含量与骨密度的相关性[J]. 中华骨质疏松和骨矿盐疾病杂志, 2013,6(1):9-14.DOI:10.3969/j.jssn.1674-2591.2013.01.003.
[21] Tsay J,Yang Z,Ross FP,et al.Bone loss caused by iron overload in a murine model: importance of oxidative stress[J].Blood,2010,116(14):2582-2589.DOI:10.1182/blood-2009-12-260083.
[22] Guggenbuhl P,Fergelot P,Doyard M,et al.Bone status in a mouse model of genetic hemochromatosis[J].Osteoporos Int,2011,22(8):2313-2319.DOI:10.1007/s00198-010-1456-2.
[23] Liu G,Men P,Kenner GH,et al.Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation[J].Biometals,2006,19(3):245-251.DOI:10.1007/s10534-005-6666-2.
[24] Xiao W,Beibei F,Guangsi S,et al.Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass[J].J Endocrinol,2015,226(3):121-134.DOI:10.1530/JOE-14-0657.
[25] Shen GS,Yang Q,Jian JL,et al.Hepcidin1 knockout mice display defects in bone microarchitecture and changes of bone formation markers[J].Calcif Tissue Int,2014,94(6):632-639.DOI:10.1007/s00223-014-9845-8.
[26] Zarjou A,Jeney V,Arosio P,et al.Ferritin ferroxidase activity: a potent inhibitor of osteogenesis[J].J Bone Miner Res,2010,25(1):164-172.DOI:10.1359/jbmr.091002.
[27] 赵理平,徐又佳,林华,等. 高铁环境对成骨细胞生物活性的影响[J]. 中华骨质疏松和骨矿盐疾病杂志, 2010,3(4):256-262.DOI:10.3969.j.issn.1674-2591.2010.04.006.
[28] Balogh E,Tolnai E,Nagy B Jr,et al.Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin[J].Biochim Biophys Acta,2016,1862(9):1640-1649.DOI:10.1016/j.bbadis.2016.06.003.
[29] Xie W,Lorenz S,Dolder S,et al.Extracellular iron is a modulator of the differentiation of osteoclast lineage cells[J].Calcif Tissue Int,2016,98(3):275-283.DOI:10.1007/s00223-015-0087-1.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(01):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(01):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(01):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(01):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(01):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(01):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]